Zim Labs Q2 FY26: net loss on revenue dip, margins tighten
ZIMLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.2 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Zim Labs posted a consolidated net loss of Rs 42 lakh in Q2 FY26 vs profit of Rs 238 lakh YoY, on revenue of Rs 88.7 cr (down from Rs 92.1 cr). For H1 FY26, net loss widened to Rs 230 lakh vs profit of Rs 328 lakh, with revenue falling about 7.8 percent to Rs 160.5 cr. Standalone Q2 PAT slipped to Rs 11.6 lakh from Rs 121.6 lakh. Higher costs and weaker sales hit profits. Operating cash flow remained positive at Rs 19.9 cr.
Weak quarterly performance with a return to losses after a profitable H1 last year. Margin pressure and revenue decline may weigh on near-term stock sentiment.